FLIPS FreeStyle Libre in Pregnancy Study
|
|
- Rafe Booth
- 6 years ago
- Views:
Transcription
1 FLIPS FreeStyle Libre in Pregnancy Study Evaluation of the Accuracy of the FreeStyle Libre Flash Glucose Monitoring System Use in Pregnancy Label Extension Study (CE) Section 1: PARTICIPANT INFORMATION SHEET We would like to invite you to take part in a research study. Before you decide whether to take part, it is important you understand why we are doing this research and what it will involve. WHY ARE WE DOING THIS STUDY? Many companies are trying to find alternatives to finger pricking for measuring blood glucose. This study compares finger prick blood glucose levels with glucose measurements obtained from the Abbott Sensor Based Glucose Monitoring System 1 ; a new system for monitoring your glucose levels. This system is already being used by adults with diabetes. The data collected during this study will be used to check that the system is accurate for use during pregnancy. 1 The Abbott Sensor Based Glucose Monitoring System is the same as the FreeStyle Libre Flash Glucose Monitoring System which is CE approved for measuring glucose levels in adults aged 18 years and older. Page 1 of 9
2 WHY HAVE I BEEN ASKED TO TAKE PART IN THIS RESEARCH? We are asking you to take part because you are at least 12 weeks pregnant and check your blood glucose levels regularly. We aim to recruit at least 80 women with diabetes from various locations within the UK and Austria, including this hospital. Unfortunately if you are allergic to plasters you will not be able to take part in this study and you should tell your doctor about this now. DO I HAVE TO TAKE PART? No, participation in this study is completely voluntary. You can leave at any time without giving a reason. WHAT IS THE DEVICE THAT IS BEING STUDIED? The Abbott Sensor Based Glucose Monitoring System measures glucose continuously and has 4 main parts: This Sensor pack and applicator consists of a disposable applicator which applies the Sensor to the back of your arm. The Reader which is used to scan the Sensor and read and store glucose data. It can also be used as a blood glucose meter into which you can insert a finger prick testing strip to obtain a blood glucose reading. A disposable Sensor that has a small, flexible Sensor tip that is inserted just under the skin. Computer-based software that can be used to upload information from the Reader. Page 2 of 9
3 The Sensor is worn continuously, with the tip under the skin. The Reader is scanned over the Sensor at any time to give a glucose reading. For this study, the Reader is masked ; this means it will not show you your glucose value when scanning the Sensor so you won t be able to use it to make decisions about treatment. This is because we don t yet know whether the system is accurate during pregnancy. However you will be able to see and use your blood glucose results when you do a finger prick test using the Reader as a glucose meter. During your final visit you will be able to use the unmasked Reader for about 30 minutes. When the system is unmasked you will be able to look at the graphs of the glucose data collected by the Sensor over the last 14 days on the Reader. WHAT DOES THE STUDY INVOLVE? If you would like to take part, we will arrange to meet you where we can discuss and explain the device. You will need to visit us each week for 3 weeks. You will also need to: Wear the sensor for 14 days. Test your blood glucose at least 4 times per day by finger pricking before every meal and at bedtime as well as testing your blood glucose as advised by your standard care team at other times of the day (eg post meal) using the Reader provided. Scan the Sensor at least every 8 hours and everytime you do a blood glucose test. Record food, exercise and insulin using the notes log on the Reader every time you test your blood glucose. Record any other events related to your pregnancy or diabetes in the paper diary provided. At some point after you have given birth, we will collect information, from your medical notes, about the outcome of your current pregnancy to include, gestational age at birth, mode of delivery, 5 minute Apgar score, infant birth weight, head circumference and if the infant is large for gestational age. You do not need to come to clinic for this activity. Page 3 of 9
4 Visit 1 (2-3hrs) Day 1 WHAT WILL I HAVE TO DO? We will talk about the research and answer any questions you may have. We will ask you to sign a consent form to say you are happy to join our study. We will ask some questions about your lifestyle (smoking and alcohol consumption), your diabetes history and any previous pregnancies. We will measure your height, weight and blood pressure. We will take a blood sample to measure your HbA1c, Fructosamine and haematocrit levels (These blood tests indicate your average glucose levels). The Sensor will be applied to the back of your arm and we will show you how to use the system including how to test your blood glucose and how to record meals, exercise and insulin on the Reader. We will ask you a couple of questions about having the Sensor applied. Call 1 (½hr approx) Day 2 A short call to check you have not had any problems and you are happy to carry on with the study. Visit 2 (½hr approx) Between Days 5 and 8 This is a quick visit to upload data from your Reader onto a study computer and check there have not been any problems and you are happy to carry on with the study. Visit 3 (2hr approx) Between Days 12 and 15 The data will be uploaded onto a study computer. We will then unmask the Reader and let you use the system unmasked for approximately 30 minutes. You will be asked to complete a questionnaire about your experience of using the system. We will take a blood sample to measure your HbA1c, Fructosamine and haematocrit levels. Page 4 of 9
5 WHAT ARE THE POSSIBLE DISADVANTAGES AND RISKS OF TAKING PART? When the sensor is applied it may be a bit uncomfortable, but from previous studies done we know that sensor insertion is almost painless (most say it is less painful than a finger prick). Once it has been inserted you will probably not notice it after a while. You may experience some mild or moderate symptoms associated with Sensor insertion or the adhesives used to keep the Sensor in place. These include infection, redness, swelling, rash, itching, bruising, pain and bleeding. There is also a possibility that unknown symptoms occur. Blood glucose testing on the Reader will require a few drops of blood per day. The risks are the same as your current blood glucose testing. These risks are small but could include pain, bruising, local infection and fainting caused by the lancet to obtain a blood sample. There are similar small risks with the collection of a blood sample for the HbA1c, Fructosamine and haematocrit blood test, plus possible dizziness. The amount of blood taken for this test may be up to about 2 teaspoons. If you have a medical appointment during the study, that includes strong magnetic or electromagnetic radiation e.g. an X-ray, MRI or CT Scan, you will have to remove the Sensor before the procedure and apply a new Sensor afterwards. WILL TAKING PART IN THE STUDY HELP ME? Taking part in the study may not benefit you; however this study will provide information about whether the glucose monitoring system is accurate during pregnancy and this may help people in the future. If you have Type 1 or Type 2 diabetes and your doctor or Nurse agrees it would be useful we will provide you with a new Reader and 2 sensors for your personal use after your pregnancy. WHAT ALTERNATIVES ARE AVAILABLE? The alternative is to carry on using your current glucose monitoring system. Page 5 of 9
6 EXPENSES AND PAYMENTS You will receive a payment of 25 per visit on completion of your final visit. These payments are to cover your travel expenses between home and the clinic including other costs incurred as part of study participation. If your travel expenses for the 3 visits are greater than 75 then additional expenses can be reimbursed on presentation of valid receipts. WILL MY INFORMATION BE KEPT PRIVATE? All information collected about you as a result of participation in the study will be kept strictly confidential. Your personal and medical information will be kept in a secured file and be treated in the strictest confidence. You may ask to see your personal information at any time. Some parts of your medical records and the data collected for the study may be looked at by people carrying out the study or people checking that the study is being carried out correctly. Except for notification to your GP of your participation in the study, nothing that could reveal your identity will be disclosed outside of the hospital. Data collected as part of this study will be looked at by authorised people from Abbott Diabetes Care who may be outside the European Union; where the laws to protect your privacy maybe different, Abbott Diabetes Care will take all reasonable steps to protect your privacy. We will seek your consent to inform your GP of your participation in this study. WHAT IF RELEVANT NEW INFORMATION BECOMES AVAILABLE? If new information becomes available that could significantly affect your future health and medical care that information shall be provided to you in writing. If necessary, you may be asked to confirm your continuing informed consent in writing. WHAT HAPPENS TO THE RESULTS OF THE RESEARCH STUDY? The results of the study will be anonymised and you will not be identified from any of the data produced. When the results of the study are available they may be published in peerreviewed medical journals and used for medical presentations and conferences. Page 6 of 9
7 WHAT WILL HAPPEN IF I DON'T WANT TO CARRY ON WITH THE STUDY? You have the right to withdraw from the study at any time. Any data/samples already collected will be retained for use in the study; however you can request that data/samples already collected are not used and are destroyed. This does not adversely affect your future medical care. The investigator may also withdraw you from the study for medical reasons or if you no longer meet the inclusion and exclusion criteria. This does not adversely affect your future medical care. WHAT IF SOMETHING GOES WRONG? If you have any cause to complain about any aspect of the way you have been approached or treated during the course of this study we suggest that you contact your study site staff or your Patient Advice and Liaison Service (PALS) at your hospital: Patient Advice and Liaison Service, John Radcliffe Hospital, Oxford University Hospitals NHS Foundation Trust, Headley Way, Oxford, OX3 9DU, palsjr@ouh.nhs.uk, Tel: Abbott Diabetes Care (ADC), the Sponsor, will provide compensation for any injury caused by taking part in this study, beyond those described as possible risks above. ADC would not be bound to pay compensation where injury resulted from a drug or procedure outside the study protocol. Please speak to your doctor or nurse to report any injury caused by taking part in this study. WHO IS ORGANISING AND FUNDING THE RESEARCH? The study is being organised and funded by Abbott Diabetes Care Limited, the manufacturers of the system being studied. WHO HAS REVIEWED THE STUDY? All research within the NHS is reviewed by an independent group of people called a Research Ethics Committee, to protect your interests. This study has been reviewed and given favourable opinion by NRES Committee Yorkshire & The Humber - Sheffield. Page 7 of 9
8 If you have any questions regarding this study please contact: Name of Doctor: Address: Dr Lucy Mackillop Oxford University Hospitals NHS Trust, Level 6, Women s Centre, Telephone: John Radcliffe Hospital, Oxford OX3 9DU Name of Study Nurses: Address: Sarah Harding, Nicola Higgins and Katy Bartlett Nuffield Department of Obstetrics & Gynaecology, Telephone: University of Oxford, Level 3, Women's Centre, John Radcliffe Hospital, Oxford OX3 9DU Thank you for taking the time to read this information sheet. You will be given a copy of this information sheet and a signed consent form to keep. Page 8 of 9
9 FLIPS FreeStyle Libre in Pregnancy Study Evaluation of the Accuracy of the FreeStyle Libre Flash Glucose Monitoring System Use in Pregnancy Label Extension Study (CE) Section 2: PARTICIPANT CONSENT FORM Participant ID: Name of Researcher: Dr Lucy Mackillop Please INITIAL in the box I confirm that I have read and understood the information sheet version 1.1, dated 20 October 2015 for the above study and have had the opportunity to consider the information, ask questions and have had these answered satisfactorily. I understand that my participation is voluntary and that I am free to withdraw at any time, without giving any reason, without my medical care or legal rights being affected. I agree to the use of my personal data for the purpose of this study and understand that relevant sections of my medical notes and data collected during the study may be looked at by responsible individuals from Abbott Diabetes Care, from regulatory authorities or from the NHS Trust, where it is relevant to my taking part in this study. I give permission for these individuals to have access to my records. 4. I agree to my GP being informed about my participation in the study. 6. I agree to take part in the above study. 7. I agree to return all study devices and materials at the end of the study. Please circle yes or no I agree to the collection of information from my medical notes, about the outcome Yes / No of my pregnancy Name of participant Signature Date Name of person taking consent Signature Date By signing above the person taking consent confirms they have checked the form to ensure it is complete. When completed: Original for Investigator s study file, 1 copy for participant and 1 copy to be kept in medical notes. Page 9 of 9
Adult Patient Information and Consent Form
The ROAM Trial Radiation versus Observation following surgical resection of Atypical Meningioma: a randomised controlled trial
More informationCouples Information Leaflet
Couples Information Leaflet This project was funded by the National Institute for Health Research, Health Technology Assessment Programme (project number 13/115/82) You are due to undergo in vitro fertilisation
More informationA study of Standard and New Antiepileptic Drugs SANAD-II
The SANAD II project is funded by the NIHR Health Technology Assessment Programme. Hospital Logo Address NIHR code A study of Standard and New Antiepileptic Drugs SANAD-II ADULT INFORMATION SHEET www.sanad2.org.uk
More informationSuspected CANcer (SCAN) Pathway Information for patients
Suspected CANcer (SCAN) Pathway Information for patients page 2 Your GP has advised you may benefit from investigation via the SCAN pathway. The SCAN pathway is part of a national programme called ACE
More informationUK Teratology Information Service Regional Drug & Therapeutics Centre Wolfson Unit Newcastle upon Tyne NE2 4HH PARTICIPANT INFORMATION SHEET
UK Teratology Information Service Regional Drug & Therapeutics Centre Wolfson Unit Newcastle upon Tyne NE2 4HH Tel: 0191 260 6197 Fax: 0191 260 6193 www.uktis.org PARTICIPANT INFORMATION SHEET Influenza
More informationSleep, Wake and Light therapy for depression
Sleep, Wake and Light therapy for depression We would like to invite you to take part in a study called Sleep, Wake and Light Therapy for treating depression You do not have to take part if you do not
More informationPATIENT INFORMATION SHEET (Sheffield and Southampton Only)
PATIENT INFORMATION SHEET (Sheffield and Southampton Only) ENDOMETRIAL SCRATCH TRIAL A Multicentre Randomised Controlled Trial of Induced Endometrial Scratch in Women Undergoing First Time in Vitro Fertilisation
More informationPatient Information Sheet
Research Trial of Treatments for Patients with Bony Metastatic Cancer of the Prostate. - TRAPEZE Patient Information Sheet Your doctor has explained to you that your prostate cancer is no longer responding
More informationVANISH Vasopressin vs Noradrenaline as Initial therapy in Septic shock
Investigator: Maurizio Cecconi Patient Information Sheet You are being invited to take part in a research study. Before you decide it is important for you to understand why the research is being done and
More informationPATIENT STUDY INFORMATION LEAFLET
PATIENT STUDY INFORMATION LEAFLET BOOKLET 1 You are invited to take part in this research study. Before you decide, it is important for you to understand why the research is being done and what it will
More informationPatient Information Sheet Opportunistic Detection of Atrial Fibrillation in Ambulatory Blood Pressure Monitoring
Patient Information Sheet Opportunistic Detection of Atrial Fibrillation in Ambulatory Blood Pressure Monitoring We'd like to invite you to take part in our research study. Before you decide if you would
More informationA study about how parts of the brain work in people with Down syndrome
A study about how parts of the brain work in people with Down syndrome Our names are Carla Startin, Sarah Hamburg and Ros Hithersay. We are researchers working at University College London. We are carrying
More informationInformation Sheet for Stage 1 Screening for parents
Chief Investigator Prof. Polly Bingley Diabetes & Metabolism Southmead Hospital Bristol BS10 5NB BETA CELL FUNCTION AND ONGOING AUTOIMMUNITY IN LONG STANDING TYPE 1 DIABETES Information Sheet for Stage
More informationPrEP Impact Trial: A Pragmatic Health Technology Assessment of PrEP and Implementation. Part 1
The Elton John Centre Sussex House 1 Abbey Road Brighton BN2 1ES Tel 01273 523079 Fax 01273 523080 PARTICIPANT INFORMATION SHEET AND CONSENT FORM PrEP Impact Trial: A Pragmatic Health Technology Assessment
More informationPATIENT STUDY INFORMATION LEAFLET
PATIENT STUDY INFORMATION LEAFLET BOOKLET 1 You are invited to take part in this research study. Before you decide, it is important for you to understand why the research is being done and what it will
More informationINFORMATION AND CONSENT FORM
INFORMATION AND CONSENT FORM A RANDOMIZED CONTROLLED TRIAL TO COMPARE THE IMMUNOGENICITY OF SELF- ADMINISTERED AND NURSE-ADMINISTERED INTRADERMAL INFLUENZA VACCINE Investigators Dr. Shelly McNeil Queen
More informationBe on the TEAM: Teenagers against Meningitis
Oxford Vaccine Group University of Oxford Centre for Clinical Vaccinology and Tropical Medicine, Churchill Hospital, Headington, Oxford OX3 7LE Tel: 01865 611400 info@ovg.ox.ac.uk www.ovg.ox.ac.uk Be on
More informationWEB device for treating brain (intracranial) aneurysms
WEB device for treating brain (intracranial) aneurysms This leaflet explains more about the WEB device, including the benefits, risks and any alternatives and what you can expect when you come to hospital.
More informationPATIENT INFORMATION SHEET
PATIENT INFORMATION SHEET Optimal management of Rheumatoid Arthritis patients who require Biologic Therapy (ORBIT study) a randomized controlled trial comparing Rituximab and anti-tnf therapy. Invitation
More informationPARTICIPANT INFORMATION SHEET Version 2 09/ IRAS Ref No.:
Mechanisms of chronic pain and fatigue PARTICIPANT INFORMATION SHEET Version 2 09/06 2017 IRAS Ref No.: 207362 We would like to invite you to take part in a research study exploring mechanisms of chronic
More informationThe role of continuous glucose monitoring as a self-monitoring behaviour change tool to enhance glycaemic control in individuals with type 2 diabetes
The role of continuous glucose monitoring as a self-monitoring behaviour change tool to enhance glycaemic control in individuals with type 2 diabetes You have been fitted with a Guardian Connect continuous
More informationGP Information Sheet
UK Teratology Information Service Regional Drug & Therapeutic Centre Wolfson Unit Newcastle upon Tyne NE2 4HH Tel: 0191 269 6197 Fax: 0191 260 6193 www.uktis.org GP Information Sheet Influenza A/H1N1v
More informationUNIVERSITY OF PENNSYLVANIA HEALTH SYSTEM
Gilead Sciences, Inc. GS-US-337-0115, 25-NOV-2013 A Phase 3, Multicenter, Open-Label Study to Investigate the Efficacy and Safety of Sofosbuvir/Ledipasvir Fixed-Dose Combination for 12 Weeks in Subjects
More informationA Phase I Study to Assess the Safety of HIV and Hep C Vaccines Candidates When Given Separately or in Combination
A Phase I Study to Assess the Safety of HIV and Hep C Vaccines Candidates When Given Separately or in Combination Sponsor: University of Oxford EudraCT No.: 2014-000730-30 REC: South Central Oxford A REC
More informationDescription of the technology
Advice Note 2017/ 001 What is the clinical effectiveness, safety and budget impact of the Freestyle Libre System compared with current glucose monitoring methods for people aged 4 years and over with diabetes
More informationWhat are the experiences of therapeutic relationships on in-patient wards by people who dissociate?
I am looking for people who may like to take part in a piece of research I am undertaking for my thesis as a part of my Clinical Psychology Doctorate. The research aims to explore how people who dissociate
More informationHow can I access flash glucose monitoring if I need it? Support pack. This pack will help you to find out more about flash and how you can access it.
How can I access flash glucose monitoring if I need it? Support pack This pack will help you to find out more about flash and how you can access it. Reviewed March 2019 Introduction Following several major
More informationPlease do not hesitate to contact us (see below) if there is anything that is not clear or if you would like more information.
PARTICIPANT INFORMATION SHEET Name of Investigator: Viren Ranawana Name of Study: The VegGI study You are invited to take part in a research study. Before you decide whether to volunteer, it is important
More informationPatient information leaflet. A study of low dose theophylline in Chronic Obstructive Pulmonary Disease (COPD)
Patient information leaflet A study of low dose theophylline in Chronic Obstructive Pulmonary Disease (COPD) Theophylline With Inhaled CorticoSteroids (TWICS) study. We would like to invite you to take
More informationAbdominal aortic aneurysm (AAA) screening Things you need to know
Abdominal aortic aneurysm (AAA) screening Things you need to know A quick, free and painless scan for men aged 65 and over Who is this leaflet for? This leaflet is for all men aged 65 and over who live
More informationPATIENT INFORMATION SHEET. BIOPROP20: Biologically optimised IMRT for Prostate Radiotherapy
PATIENT INFORMATION SHEET BIOPROP20: Biologically optimised IMRT for Prostate Radiotherapy Hypofractionated radiotherapy with intra-prostatic boosts to tumour nodules in men with intermediate and high
More informationCOUPLE INFORMATION SHEET AND INFORMED CONSENT FORM
Hyaluronic Acid Binding Sperm selection for ICSI (Intracytoplasmic Sperm Injection) COUPLE INFORMATION SHEET AND INFORMED CONSENT FORM We invite you to take part in a research study called HABSelect Before
More informationBarrett s Oesophagus
PATIENT INFORMATION Barrett s Oesophagus Radiofrequency Ablation of Barrett s Columnar Lined Oesophagus and Squamous Dysplasia MulticentreTrial with Long Term Follow Up Using a Central Database Project
More informationHREC/17/RCHM/334 RCH HREC 37278A. ANZ CLARITY Establishment of a National Juvenile Idiopathic Arthritis Biobank.
HREC Project Number: Research Project Title: Principal Researchers: HREC/17/RCHM/334 RCH HREC 37278A ANZ CLARITY Establishment of a National Juvenile Idiopathic Arthritis Biobank. Associate Professor Justine
More informationPARTICIPANT INFORMATION SHEET. Clinical trial to evaluate a new Hepatitis B vaccine (CONSTANT study)
Oxford Vaccine Group University of Oxford Centre for Clinical Vaccinology and Tropical Medicine, Churchill Hospital, Headington, Oxford OX3 7LE Telephone: 01865 611400 info@ovg.ox.ac.uk www.ovg.ox.ac.uk
More informationTHE SHEFFIELD AREA PRESCRIBING GROUP. Position Statement for Prescribing of Freestyle Libre In Type 1 Diabetes. Date: March 2018.
THE SHEFFIELD AREA PRESCRIBING GROUP Position Statement for Prescribing of Freestyle Libre In Type 1 Diabetes Date: March 2018 Overview Freestyle Libre is a flash glucose sensor device that measures *interstitial
More informationPatient Information Sheet. PSC Cohort
Analysis of liver infiltrating lymphocytes in primary sclerosing cholangitis by fine needle aspiration of the liver. Patient Information Sheet PSC Cohort Chief Investigator: Dr Kate Williamson Investigators:
More informationUNIVERSITY OF PENNSYLVANIA HEALTH SYSTEM
White Blood Cell Collection by Leukapheresis in HIV-infected Individuals On Chemotherapy and Controls Not on Chemotherapy: A Study of HIV Reservoir Eradication CONSENT TO PARTICIPATE IN A RESEARCH STUDY
More informationAbout this consent form. Why is this research study being done? Partners HealthCare System Research Consent Form
Protocol Title: Gene Sequence Variants in Fibroid Biology Principal Investigator: Cynthia C. Morton, Ph.D. Site Principal Investigator: Cynthia C. Morton, Ph.D. Description of About this consent form Please
More informationVanderbilt University Institutional Review Board Informed Consent Document for Research. Name of participant: Age:
This informed consent applies to: Adults Name of participant: Age: The following is given to you to tell you about this research study. Please read this form with care and ask any questions you may have
More informationUNIVERSITY OF PENNSYLVANIA RESEARCH SUBJECT INFORMED CONSENT FORM
UNIVERSITY OF PENNSYLVANIA RESEARCH SUBJECT INFORMED CONSENT FORM Protocol Title: Principal Investigator: Emergency Contact: AN OPEN LABEL TRIAL OF MECASERMIN FOR HIV ASSOCIATED METABOLIC DISEASE Roy Kim
More informationChildren & Young People Travelling with Type 1 Diabetes
Children & Young People Travelling with Type 1 Diabetes Advice on what to do to prepare for your holiday when you have type 1 diabetes Paediatric Diabetes Patient Information Leaflet Preparation Before
More information<Delete this line and print on hospital headed paper> Euro Ewing 2012
International Randomised Controlled Trial for the Treatment of Newly Diagnosed Ewing's Sarcoma Family of Tumours PARENT INFORMATION SHEET R1 We would
More informationParticipant Information Leaflet
Participant Information Leaflet Research: Hand to nose transmission of Streptococcus pneumoniae in healthy participants: randomised control trial assessing the effect of hand Would you like to take part
More informationUNIVERSITY OF CALIFORNIA, SAN FRANCISCO CONSENT TO BE IN RESEARCH
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CONSENT TO BE IN RESEARCH CC#:125519: Radiologically Guided Biopsies Of Metastatic Castration Resistant Prostate Cancer to Identify Adaptive Mechanisms Of Resistance
More informationWe are doing some research. It is about practising standing up early. after stroke. Research helps us learn. We need to know more about how to
The research story What is the research? We are doing some research It is about practising standing up early after stroke Research helps us learn We need to know more about how to help people
More informationINFORMATION BROCHURE - ALLOCATE
INFORMATION BROCHURE - ALLOCATE AustraLian Ovarian Cancer Assortment Trial Principal Investigator: Prof Michael Quinn, Royal Women s Hospital This Participant Information Sheet and Consent Form is 7 pages
More informationPARTICIPANT INFORMATION SHEET: EBL04
Professor Adrian Hill E-mail: vaccinetrials@ndm.ox.ac.uk Tel: 01865 857406 INSERT LOCAL DETAILS NRES Committee South Central - Oxford A ref number:15/sc/0108 PARTICIPANT INFORMATION SHEET: EBL04 A study
More informationAbout this consent form
Protocol Title: Development of the smoking cessation app Smiling instead of Smoking Principal Investigator: Bettina B. Hoeppner, Ph.D. Site Principal Investigator: n/a Description of Subject Population:
More informationUNIVERSITY OF PENNSYLVANIA HEALTH SYSTEM. A Pilot Study for Collection of Anti-Zika Immune Plasma
A Pilot Study for Collection of Anti-Zika Immune Plasma CONSENT TO PARTICIPATE IN A RESEARCH STUDY AND RESEARCH SUBJECT HIPAA AUTHORIZATION Your contacts for this study at the Hospital of the University
More informationCONSENT TO PARTICIPATE IN A RESEARCH STUDY. Why are you being invited to take part in a research study?
HRP-502 (6/1/2016) LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER in Shreveport Institutional Review Board (IRB) for the Protection of Human Research Subjects Remove all instructional text and red color-coding
More informationPostnatal Care for Women with Type 1 or Type 2 Diabetes
Postnatal Care for Women with Type 1 or Type 2 Diabetes Maternity Patient Information Leaflet Introduction Congratulations! Now you have had your baby, your insulin requirements will be reduced. This is
More informationAutism Action Network Charter
Autism Action Network Charter Introduction The Autism Action Network is an exciting opportunity for you to be part of a passionate community committed to helping people with autism to live the life they
More informationUNIVERSITY OF CALIFORNIA, SAN FRANCISCO CONSENT TO PARTICIPATE IN A RESEARCH STUDY
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CONSENT TO PARTICIPATE IN A RESEARCH STUDY Study Title: Assessment of Biochemical Pathways and Biomarker Discovery in Autism Spectrum Disorder This is a research
More informationUNIVERSITY OF PENNSYLVANIA HEALTH SYSTEM. A5272 Version 2.0, 5/19/11: Oral HPV Shedding and Oral Warts After Initiation of Antiretroviral Therapy
A5272 Version 2.0, 5/19/11: Oral HPV Shedding and Oral Warts After Initiation of Antiretroviral Therapy CONSENT TO PARTICIPATE IN A RESEARCH STUDY AND RESEARCH SUBJECT HIPAA AUTHORIZATION Your contacts
More informationThe Johns Hopkins Bloomberg School of Public Health
The Johns Hopkins Bloomberg School of Public Health CONSENT FORM A / NEW RESEARCH PROJECT Title of Research Project: A Randomized Trial of HAART in Acute/Early HIV Infection Version 3.0 Principal Investigator:
More informationCardiac Magnetic Resonance Imaging (MRI)
Cardiac Magnetic Resonance Imaging (MRI) Radiology Department Patient information leaflet This leaflet tells you about having an MRI Cardiac scan. It explains what is involved and the possible risks. It
More informationINFORMATION AND CONSENT FORM For Adults Aged 18 and Older Additional Facility Sites
INFORMATION AND CONSENT FORM Program Title: Expanded Access IND Program to Provide Stamaril Vaccine to Persons in the United States for Vaccination Against Yellow Fever Program #: Sponsor: Sanofi Pasteur
More informationCONSENT FORM. The Full Study Title Should Be Placed Here. Principal Investigator: Dr. John Smith Sub-Investigator: Dr. Jane Smith
CONSENT FORM The Full Study Title Should Be Placed Here. Principal Investigator: Dr. John Smith Sub-Investigator: Dr. Jane Smith Queen Elizabeth Hospital Queen Elizabeth Hospital 60 Riverside Drive 60
More informationSMOKING CESSATION STUDY SERVICE USER INFORMATION SHEET. Thank you! Information about our research and invitation to take part in our study
believe that this study is safe and do not expect you to suffer any harm or injury because of your participation in it. However, Queen Mary University of London has agreed that if you are harmed as a result
More informationYour visit to the Breast Clinic. Information for patients Breast Services
Your visit to the Breast Clinic Information for patients Breast Services This leaflet will provide you with information about the Breast Clinic and what might happen during your appointment. If after reading
More informationFlash Glucose Monitoring (Flash GM) Frequently asked questions (November 2018)
Flash Glucose Monitoring (Flash GM) Frequently asked questions (November 2018) What is Flash Glucose Monitoring (Flash GM)? Flash glucose monitoring is a small sensor that you wear on your skin (usually
More informationStudy information booklet
Oxford Vaccine Group University of Oxford Centre for Clinical Vaccinology and Tropical Medicine, Churchill Hospital, Headington, Oxford OX3 7LE Telephone: 01865 611400 info@ovg.ox.ac.uk www.ovg.ox.ac.uk
More informationHEALTH RECORD REASON FOR THIS VISIT ABOUT YOU ABOUT YOUR SPOUSE HEALTH HABITS EXPERIENCE WITH CHIROPRACTIC
HEALTH RECORD ABOUT YOU REASON FOR THIS VISIT Name Address City State Zip _Home phone Birth date Cell Phone Age Gender Number of children Employer Work address Work phone Occupation Marital Status Social
More informationThe OptiMuM Study Optimal Nutrition in the Elderly: High Protein Diets for Muscular, Metabolic, and Microbiome Health
OPTIMUM 1 Subject ID: I I I I I I I Subject Name: Date of Birth: / / The OptiMuM Study Optimal Nutrition in the Elderly: High Protein Diets for Muscular, Metabolic, and Microbiome Health PARTICIPANT INFORMATION
More informationHaving a kidney biopsy. Information for patients Sheffield Kidney Institute (Renal Unit)
Having a kidney biopsy Information for patients Sheffield Kidney Institute (Renal Unit) This leaflet is designed to answer any questions you may have about having a biopsy of your kidney. We hope that
More informationQuick Reference Guide
FLASH GLUCOSE MONITORING SYSTEM Quick Reference Guide IMPORTANT USER INFORMATION Before you use your System, review all the product instructions and the Interactive Tutorial. The Quick Reference Guide
More informationUNIVERSITY OF PENNSYLVANIA RESEARCH SUBJECT INFORMED CONSENT AND HIPAA AUTHORIZATION FORM
UNIVERSITY OF PENNSYLVANIA RESEARCH SUBJECT INFORMED CONSENT AND HIPAA AUTHORIZATION FORM Protocol Title: Principal Investigator: 24 hr. Emergency Contact: Evaluating the HIV-1 Reservoir: BEAT HIV Delaney
More informationBIOmarkers in DEPression (BIODEP) Information Sheet for Healthy Volunteers
BIOmarkers in DEPression (BIODEP) Information Sheet for Healthy Volunteers You are being invited to take part in a research study. This leaflet explains why the research is being done and what taking part
More informationTitle of Research Study: Discovery and Validation of Biomarkers for Lichen Sclerosus
Page 1 of 8 Informed Consent for Participation in a Research Study Title of Research Study: Discovery and Validation of Biomarkers for Lichen Sclerosus Investigator Contact Information: Principal Investigator:
More informationQuick Reference Guide
FLASH GLUCOSE MONITORING SYSTEM Quick Reference Guide IMPORTANT USER INFORMATION Before you use your System, review all the product instructions and the Interactive Tutorial. The Quick Reference Guide
More informationBreast Screening. Helping you decide
Breast Screening Helping you decide It is up to you if you want to have breast screening or not. This leaflet will help you decide. Why does the NHS offer breast screening? The NHS offers breast screening
More informationSTUDIES INVOLVING THE NON-INVASIVE MEASUREMENT OF BLOOD PRESSURE IN THE ARM
STUDIES INVOLVING THE NON-INVASIVE MEASUREMENT OF BLOOD PRESSURE IN THE ARM 1. SCOPE Blood pressure is a vital sign that is used in many clinical situations, and assesses the pressure of blood as it flows
More informationInformation for patients having a barium follow-through (small bowel meal)
Information for patients having a barium follow-through (small bowel meal) The leaflet tells you about having a barium follow-through. It explains what is involved and what the possible risks are. It is
More informationCT Guided Lung Biopsy. Patient Information
CT Guided Lung Biopsy Patient Information Author ID: VS Leaflet Number: Rad 021 Version: 1 Name of Leaflet: CT Guided Lung Biopsy Date Produced: April 2017 Review Date: April 2019 Introduction What is
More informationUltrasound guided neck lump biopsy
Ultrasound guided neck lump biopsy Information for patients Diagnostic Imaging Department X-Ray and Scanning Specialist Support If you require this leaflet in another language, large print or another format,
More informationIRB Approval From: 3/8/2010 To: 10/28/2010
UNIVERSITY OF PENNSYLVANIA HEALTH SYSTEM Phase II Study to Assess the Safety and Immunogenicity of an Inactivated Swine-Origin H1N1 Influenza Vaccine in HIV-1 (Version 3.0, 16 FEB 2010) IRB Approval From:
More informationRadiology Patient Information Leaflet
Your CT Scan in the Radiology Department Radiology Patient Information Leaflet Welcome to the Radiology Department The radiology department may also be called the X-ray or imaging department. It is the
More informationSphenopalatine ganglion (SPG) stimulation for the treatment of cluster headaches
Headache Centre Sphenopalatine ganglion (SPG) stimulation for the treatment of cluster headaches This leaflet is for patients, family and carers. It explains about the benefits, risks and any alternatives
More informationAutologous plasma eye drops. Patient information
Autologous plasma eye drops Patient information Autologous plasma eye drops are made from the patient s own blood and are used to help treat their corneal surface defects and diseases. This leaflet gives
More informationPARTICIPANT INFORMATION SHEET: EBL01
Professor Adrian Hill E-mail: vaccinetrials@ndm.ox.ac.uk Tel: 01865 857406 NRES Committee South Central - Oxford A ref number: 14/SC/1256 Jenner Institute University of Oxford CCVTM, Churchill Hospital,
More informationHaving MR Small Bowel (MR Enterography)
Having MR Small Bowel (MR Enterography) Information for Patients In this leaflet: Introduction 2 What is an MR Small Bowel?..2 What do I need to do to before my scan?....2 Where do I go when I arrive at
More informationProblem Situation Form for Parents
Problem Situation Form for Parents Please complete a form for each situation you notice causes your child social anxiety. 1. WHAT WAS THE SITUATION? Please describe what happened. Provide enough information
More informationDO IT TIPS & TRICKS YOU CAN WITHOUT LANCETS * with FreeStyle Libre FLASH GLUCOSE MONITORING SYSTEM
FLASH GLUCOSE MONITORING SYSTEM YOU CAN DO IT WITHOUT LANCETS * TIPS & TRICKS with FreeStyle Libre *Scanning the sensor to obtain glucose values does not require lancets. FreeStyle Libre overview 1 The
More informationBristol Children s Vaccine Centre
Bristol Children s Vaccine Centre Bristol Children s Vaccine Centre Level 6, UHB Education Centre, Upper Maudlin St., Bristol, BS2 8AE, UK Tel: +44 (0)117 342 0172, Fax: +44 (0)117 342 0209 E-mail: bcvc-study@bristol.ac.uk,
More informationHome intravenous and intramuscular antibiotics
Home intravenous and intramuscular antibiotics Children s Community Nursing Service 0161 206 2370 All Rights Reserved 2018. Document for issue as handout. This booklet has been given to you because your
More informationPhysical Evidence Chiropractic 7035 Beracasa Way, Suite 103 Boca Raton Florida, Phone# (561) Fax# (561)
7035 Beracasa Way, Suite 103 Boca Raton Florida, 33433 Phone# (561)674-1217 Fax# (561)361-4999 Date File # PERSONAL HISTORY Last Name First Name middle Address City State Zip Date of Birth Age Social Security
More informationUNIVERSITY OF PENNSYLVANIA HEALTH SYSTEM CONSENT TO PARTICIPATE IN A LONG TERM FOLLOW UP TO A RESEARCH STUDY AND RESEARCH SUBJECT HIPAA AUTHORIZATION
UNIVERSITY OF PENNSYLVANIA HEALTH SYSTEM CONSENT TO PARTICIPATE IN A LONG TERM FOLLOW UP TO A RESEARCH STUDY AND RESEARCH SUBJECT HIPAA AUTHORIZATION Protocol No. VRX496-USA-11-001-LTFU: Long-term Follow-up
More informationA CT guided cervical nerve block (Root block)
Patient information leaflet Royal Surrey County Hospital NHS Foundation Trust A CT guided cervical nerve block (Root block) Radiology Department The leaflet tells you about having a computerised tomography
More informationShort course radiotherapy for lung cancer
Notes: Royal Berkshire NHS Foundation Trust London Road, Reading RG1 5AN Telephone 0118 322 5111 This document can be made available in other languages and formats upon request. BCC_528 Author: Catherine
More informationInformation leaflet for patients and families. Skin Biopsy
Information leaflet for patients and families Skin Biopsy What is a punch skin biopsy? This is a short procedure to remove a small piece of skin. The skin may be examined under a microscope. Often we grow
More informationUniversity of Pennsylvania RESEARCH Subject Informed Consent Form AND RESEARCH SUBJECT HIPAA AUTHORIZATION
University of Pennsylvania RESEARCH Subject Informed Consent Form AND RESEARCH SUBJECT HIPAA AUTHORIZATION Protocol Title: Evaluating the impact of cocaine use and HIV infection in arterial wall inflammation
More informationGlucose Tolerance Test. Women s and Children s Services
Glucose Tolerance Test Women s and Children s Services General Information This leaflet is designed to give information regarding your Glucose Tolerance Test (GTT). Please make the appointments for this
More informationIRB Approved: 09-Jan-2015 To: 08-Jan-2016
Developing Assays to Evaluate Immunologic Response to HIV and HIV Vaccines CONSENT FORM/HIPAA AUTHORIZATION FOR VENIPUNCTURE Investigators: Pablo Tebas, MD Phone Number: (215) 349-8092 Study Staff: Joseph
More informationVideo swallow examination
Radiology Department John Radcliffe Hospital and Churchill Hospital Video swallow examination Information for patients Video swallow examination The radiology department has received a request for you
More informationBevacizumab (Avastin ) treatment for Neurofibromatosis Type 2 (NF2) Information for patients
Bevacizumab (Avastin ) treatment for Neurofibromatosis Type 2 (NF2) Information for patients This booklet has been written to give you more information about bevacizumab (commonly known as Avastin). This
More informationHelping you decide 2014 edition Easy Read
Breast Screening Helping you decide 2014 edition Easy Read We have made this leaflet as accessible as possible. There are still some difficult ideas in it. You might need to ask a friend, family member,
More informationChild and Adolescent Mental Health Service (CAMHS)
Oxford Health NHS Foundation Trust CAMHS Child and Adolescent Mental Health Service (CAMHS) CAMHS Introduction Welcome to Oxford Health NHS Foundation Trust. This leaflet aims to provide you with answers
More informationINFORMATION SHEET FOR THE DEPARTMENT OF PAIN AND PALLIATIVE CARE
INFORMATION SHEET FOR THE DEPARTMENT OF PAIN AND PALLIATIVE CARE Please review the following instructions as it contains important information regarding the management of your pain. Once reviewed, our
More information